Government ministers and officials were following Prime Minister Narendra Modi lead by opting on Tuesday for an Indian-made COVID-19 vaccine approved without late-stage efficacy data, instead of the AstraZeneca one.
India’s health, foreign and law ministers, and state governors, all flocked to Twitter to express support for the much-criticized Bharat Biotech’s COVAXIN vaccine, after it was administered to Modi on Monday.
“Made-in-India vaccines are 100 percent safe,” Health Minister Harsh Vardhan said after being inoculated with COVAXIN.
Many state officials and doctors have refused to take COVAXIN before its effectiveness could be proved. Bharat Biotech says it has completed the late-stage trial and results will be out this month.
The company said the endorsement by Modi and other ministers would set an example for other Indians and reduce “vaccine hesitancy”. It is seeking to sell COVAXIN to countries including Brazil and the Philippines.
COVAXIN and the AstraZeneca vaccines were approved by India’s regulator in January. The government has distributed to states a total of 50 million doses of the vaccines but only 12 percent of the 12 million people immunized so far have taken COVAXIN, according to government data.
Brazil prosecutors seek immediate halt of purchases of India’s COVID-19 vaccineBrazilian prosecutors are seeking the immediate suspension of purchases of India’s COVID-19 vaccine COVAXIN, according to a document seen by Reuters ... Coronavirus
India says COVID-19 virus variants not behind upsurge in cases in two statesIndia said on Tuesday mutated versions of coronavirus were not responsible for an upsurge in cases in two states, a potential relief for a country ... Coronavirus
Resurgence of COVID-19 in India’s Maharastra forces fresh containment measuresAlarmed by signs that a second wave of the coronavirus epidemic is building, India’s richest state of Maharashtra ordered fresh restrictions on ... Coronavirus
India’s dramatic fall in COVID-19 cases leaves experts stumpedWhen the coronavirus pandemic took hold in India, there were fears it would sink the fragile health system of the world’s second-most populous country ... Coronavirus